XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
OPERATING ACTIVITIES:    
Net Income $ 59,110 $ 63,071
Items not affecting cash:    
Depreciation and depletion 48,905 46,975
Amortization of debt issuance costs, discount and deferred hedge gain 1,270 1,303
Stock-based compensation costs 2,757 3,223
Equity portion of allowance for funds used during construction (3,116) (1,985)
Gain on disposition of assets (1) (57)
Deferred income taxes (6,558) (2,706)
Changes in current assets and liabilities:    
Accounts receivable 24,936 5,230
Inventories 10,005 4,183
Other current assets 1,181 (455)
Accounts payable (3,432) (16,591)
Accrued expenses and other 46,119 63,169
Regulatory assets 14,961 (54,195)
Regulatory liabilities (1,003) (23,228)
Other noncurrent assets 7,153 (1,682)
Other noncurrent liabilities (6,621) (20,656)
Cash Provided by Operating Activities 195,666 65,599
INVESTING ACTIVITIES:    
Property, plant, and equipment additions (115,502) (77,854)
Investment in equity securities (567) 0
Cash Used in Investing Activities (116,069) (77,854)
FINANCING ACTIVITIES:    
Dividends on common stock (33,901) (31,124)
Issuance of long-term debt, net 0 99,915
Line of credit (repayments) borrowings, net (33,000) 49,000
Repayments of short-term borrowings 0 (100,000)
Cash (Used in) Provided by Financing Activities (67,461) 17,049
Increase in Cash, Cash Equivalents, and Restricted Cash 12,136 4,794
Cash, Cash Equivalents, and Restricted Cash, beginning of period 18,762 17,096
Cash, Cash Equivalents, and Restricted Cash, end of period  30,898 21,890
Cash paid during the period for:    
Interest 14,152 13,765
Significant non-cash transactions:    
Capital expenditures included in accounts payable 17,156 18,089
Proceeds from (Payments for) Other Financing Activities $ (560) $ (742)